Digital health technology company NeuroRPM has received FDA 510(k) clearance for its AI-enabled remote monitoring app that utilizes an Apple Watch to track common Parkinson's symptoms such as bradykinesia, tremor and dyskinesia.
Bradykinesia is slowness of movement, and dyskinesia is involuntary or erratic movements.
The Washington D.C.-based company's algorithms are embedded in the Apple Watch...
